Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: Injection
Still deciding? Get samples of US$ 0/Piece
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
Management Certification
The supplier has quality management system certification, including:
ISO9001:2015 certificate
ISO45001:2018 certificate
ISO14001
to see all verified strength labels (20)
  • Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm
  • Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm
  • Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm
  • Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm
  • Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm
  • Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm
Find Similar Products

Basic Info.

Model NO.
AMC12004
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Oral Liquid
Type
Biological Products
Pharmaceutical Technology
Chemical Synthesis
Function
Antimalarial
Standard Available
Bp, Cp
OEM/ODM
Support
Delivery Time
30~60 Days
Transport Package
6′s/Box 500boxes/CTN
Specification
80mg/1ml
Trademark
Shinepharm
Origin
China
HS Code
3004909099
Production Capacity
1000000box/Month

Product Description


Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm

Antimalarial Drug 80mg/1ml Artemether Injection with Shinepharm

Indications:

Antimalarial drug for the treatment of all kinds of malaria, including chloroquine-resistant P. falciparum malaria and first aid for critical malaria.

Usage and Dosage:

Administered via intramuscular injection. Five-day course with an initial dose of 3.2mg/kg, followed by 1.6mg/kg for the next 4 days. Adults: initial dose of 160mg (2 ampoules), followed by 80mg (1 ampoule) daily from day 2 to day 5. Adjust dosage for children or overweight patients based on weight or doctor's prescription.

Adverse Reactions:

Clinical dosage may cause transient low fever, reticulocytopenia, slight rise in SGOT and SGPT, and rare cases of arrhythmia (e.g., ventricular tachycardia).

Pregnancy and Lactation:

Use with caution in the first trimester of pregnancy due to observed fetal absorption. Consult a doctor for administration to children.

Drug Interactions:

Studies show no interactions with other drugs affecting therapeutic effects or increasing toxicity in the body.

Overdosage:

No documented cases, but in case of accidental overdose, seek symptomatic treatment under doctor's guidance.

Company name: Anhui Medipharm Co., Ltd.

Antimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with ShinepharmAntimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with ShinepharmAntimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with ShinepharmAntimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with ShinepharmAntimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with ShinepharmAntimalarial Drug for Malaria Treatment 80mg/1ml Artemether Injection with Shinepharm

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier